MARKET INSIGHT: Biopharmaceutical CDMOs Analysis Update
The primary purpose of this Market Insight update is to evaluate the current status of the Biopharmaceutical Contract Development and Manufacturing (“CDMO”) industry as of 1H 2019. This report serves to further analyze the information provided in Bourne Partners’ Biopharmaceutical CDMOs Analysis Market Insight report from February 2019, as well as to expand upon the drivers and trajectory of the biopharmaceutical CDMO market. The trend of biopharmaceutical CDMO consolidation has continued throughout 1H 2019, with a number of high-profile acquisitions and investments. The increased industry consolidation has been primarily driven by broad growth across the biopharmaceutical sector.
Click here to view this report in its entirety.